ARX's CoSign Digital Signatures are SAFE-BioPharma Certified

San Francisco , California June 24, 2008

ARX (Algorithmic Research), a leading provider of digital signatures (standard electronic signatures) that ensure document integrity, announced today that CoSign®, its digital signature solution, has been certified by SAFE-BioPharma™. CoSign is the most widely used digital signature technology in the BioPharma industry. 

"This advancement not only enables companies to implement the strong user authentication put forth by SAFE-BioPharma, but also eliminates tokens, smartcards, and proprietary software, for substantial cost savings of 75 to 90 percent," said Rodd Schlerf, Life Sciences and Healthcare Manager, ARX.

CoSign's centralized digital signature (PKI-based) design enables the signer’s credentials to be accessed centrally from any network or web portal in any location. In addition to the speed and security with which digital signatures can be obtained, CoSign establishes a legally-binding audit trail.

"CoSign's certification provides the level of confidence SAFE-BioPharma members seek in implementing SAFE-BioPharma solutions. This is truly a win-win development for both ARX and SAFE-BioPharma," said Mollie Shields-Uehling, President and CEO, SAFE-BioPharma Association. 

By agreeing to SAFE-BioPharma’s credentialing standards, pharmaceutical companies reduce the cost and duration of business processes, speeding product development.

About SAFE-BioPharma

SAFE-BioPharma Association is the non-profit association that created and manages the SAFE-BioPharma™ digital identity and signature standard for the pharmaceutical and healthcare industries. The SAFE-BioPharma industry standard is used to mitigate legal, regulatory and other business risk associated with business-to-business and business-to-regulator electronic transactions. It facilitates interoperability by providing a secure, enforceable, and regulatory-compliant way to verify identities of parties involved in electronic transactions. SAFE-BioPharma’s vision is to be a catalyst in transforming the biopharmaceutical and healthcare communities to a fully electronic business environment by 2012. The Association’s members include Amgen (NASDAQ: AMGN), AstraZeneca (NYSE: AZN), Bristol-Myers Squibb (NYSE:BMY), Genzyme (NASDAQ: GENZ), GlaxoSmithKline (NYSE: GSK), Johnson & Johnson (NYSE: JNJ), Merck (NYSE:MRK), Pfizer (NYSE: PFE), Procter & Gamble (NYSE: PG), Roche and Sanofi-Aventis (NYSE:SNY). For more information, visit www.safe-biopharma.org.  

CoSign makes it easy to digitally sign transactions, documents, and records by embedding the standard signature technology directly into mainstream business applications. CoSign produces a signature record for every signature it captures. This Portable Signature Format (CoSign PSF™) allows anyone to seamlessly verify and retain proof of identity, intent, and document integrity without costly, complicated, or proprietary software. CoSign keeps your business running smoothly by fully automating and quickly scaling processes at a low cost and with proper controls. Learn more at www.arx.com/products/cosign_moreinfo.php.

About ARX - The Digital Signature Company

ARX (Algorithmic Research) is a global provider of cost-efficient digital signature solutions for industries such as life sciences, healthcare, government, and engineering. ARX engineers and scientists have more than 20 years of experience in security and standard digital signature application. ARX helps businesses secure, streamline, and scale their business processes and transactions with the proper controls required by legislation, regulation, and industry best practice. Visit us at www.arx.com.

###

CoSign and SAPI are registered trademarks and CoSign PSF is a trademark of Algorithmic Research, Ltd. All other trade names and trademarks are the property of their respective holders.

Press Contact:
Edna Kaplan
KOGS Communication
781-639-1910/phone
kaplan@kogspr.com